112
Views
66
CrossRef citations to date
0
Altmetric
Research Article

Arsenic-induced oxidative cerebral disorders: Protection by taurine

, , , &
Pages 93-102 | Received 16 Jul 2008, Accepted 25 Aug 2008, Published online: 01 Apr 2009

References

  • Alves EW, de Meis L. (1987). Effects of arsenate on the Ca2+ ATPase of sarcoplasmic reticulum. Eur. J. Biochem. 166:647–651.
  • Banks MA, Porter WD, Martin WG, Castranova V. (1992). Taurine protects against oxidant injury to rat alveolar pneumocytes. Adv. Exp. Med. Biol. 315:341–354.
  • Benzie IFF, Strain JJ. (1999). Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 299:15–27.
  • Bonaventura J, Schroeder WA, Fang S. (1972). Human erythrocyte catalase: an improved method of isolation and a reevaluation of reported properties. Arch. Biochem. Biophys. 150:606–617.
  • Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.
  • Calderon RL, Abernathy CO, Thomas DJ. (2004). Consequences of acute and chronic exposure to arsenic in children. Pediatr. Ann. 33:461–466.
  • Campbell JP, Alvarez JA. (1989). Acute arsenic intoxication. Am. Fam. Physician. 40:93–97.
  • Chiou HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei ML, Chen CJ. (2001). Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am. J. Epidemiol. 153:411–418.
  • Das D, Chatterjee A, Mandal BK, Samanta G, Chakraborti D. (1995). Arsenic in groundwater in six districts of West Bengal, India, The biggest arsenic calamity in the world. Part II. Arsenic concentration in drinking water, hair, nails, urine, skin-scale, and liver tissue (biopsy) of the affected people. Analyst 120:917–924.
  • Dogru-Abbasoglu S, Kanbagli O, Balkan J, Cevikbas U, Aykac-Toker G, Uysal M. (2001). The protective effect of taurine against thioacetamide hepatotoxicity of rats. Hum Exp Toxicol. 20:23–27.
  • Dolphin D. (1989). Glutathione: chemical, biochemical, and medical aspects (part A and B). New York: Wiley.
  • Ellman GL. (1959). Tissue sulfhydryl group. Arch. Biochem. Biophys. 82:70–77.
  • Ellman GL, Courtney KD, Andres VJ, Featherstone RMA. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:88–95.
  • Erdem A, Gündoğan NU, Usubütün A, Kilinç K, Erdem SR, Kara A, Bozkurt A. (2000). The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats. Nephrol. Dial. Transpl. 15:1175–1182.
  • Esterbauer H, Cheeseman KH. (1990). Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Meth. Enzymol. 186:407–421.
  • Evans Jr., DJ. (1969). Membrane adenosine triphosphate of E. coli. activation by calcium ions and inhibition by monovalent cations. J. Bacteriol. 100:914–922.
  • Flohe L, Gunzler WA. (1984). Assay of glutathione peroxidase. Meth. Enzymol. 105:114–121.
  • Fulladosa E, Murat JC, Bollinger JC, Villaescusa I. (2007). Adverse effects of organic arsenical compounds towards Vibrio fischeri bacteria. Sci. Total Environ. 377:207–213.
  • Gebel T. (1997). Arsenic and antimony: comparative approach on mechanistic toxicology. Chem. Biol. Interact. 107:131–144.
  • Goering PL, Aposhian HV, Mass MJ, Cebrian M, Beck BD, Waalkes MP. (1999). The enigma of arsenic carcinogenesis: role of metabolism. Toxicol. Sci. 49:5–14.
  • Gonzalez MJ, Aguilar MV, Martinez MC. (1997). Mechanism of absorption of As2O5 from rat small intestine: the effect of different parameters. J. Trace Elem. Med. Biol. 11:239–247.
  • Habig WH, Pabst MJ, Jakoby WB. (1974). Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249:7130–7139.
  • Hissin PJ, Hilf RA. (1976). A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74:214–226.
  • Hjertan S, Pan H. (1983). Purification and characterization of two forms of a low-affinity Ca2+-ATPase from erythrocyte membranes. Biochim. Biophys. Acta. 728:281–288.
  • Hughes MF. (2002). Arsenic toxicity and potential mechanisms of action. Toxicol. Lett. 133:1–16.
  • Huxtable RJ. (1992). Physiological action of taurine. Physiol. Rev. 72:101–163.
  • Jiang ZY, Hunt JV, Wolff SP. (1992). Detection of lipid hydroperoxide using the FOX method. Anal. Biochem. 202:384–389.
  • Kaltreider RC, Pesce CA, Ihnat MA, Lariviere JP, Hamilton GW. (1999). Differential effects of arsenic (III) and chromium(VI) on nuclear transcription factor binding. Mol. Carcinogen. 25:219–229.
  • Liu YC, Huang H. (1997). Involvement of calcium-dependent protein kinase C in arsenite-induced genotoxicity in Chinese hamster ovary cells. J. Cell. Biochem. 64:423–433.
  • Mallick P, Chakrabarti Mallick J, Guha B, Khuda-Bukhsh AR. (2003). Ameliorating effect of microdoses of a potentized homeopathic drug, Arsenicum Album, on arsenic induced toxicity in mice. BMC Complement. Altern. Med. 3:7.
  • Manna P, Sinha M, Sil PC. (2008). Protection of arsenic-induced testicular oxidative stress by arjunolic acid. Redox Report. 13:67–77.
  • Milei J, Ferreira R, Llesuy S, Forcada P, Covarrubias J, Boveris A. (1992). Reduction of reperfusion injury with preoperative rapid intravenous infusion of taurine during myocardial revascularization. Am. Heart J. 123:339–345.
  • Nakashima T, Taniko T, Kuriyama K. (1982). Therapeutic effect of taurine administration on carbon tetrachloride-induced hepatic injury. Jap. J. Pharmacol. 32:583–589.
  • Ohnishi T, Suzuki T, Suzuki Y, Ozawa K. (1982). A comparative study of plasma membrane Mg2+-ATPase activities in normal, regenerating and malignant cells. Biochim. Biophys. Acta. 684:67–74.,
  • Olney JW, Collins RC, Sloviter RS. (1986). Exotoxic mechanism of epileptic brain damage. Adv. Neurol. 44:857–877.
  • Pakulska D, Czerczak S. (2006). Hazardous effects of arsine: a short review. Int. J. Occup. Med. Environ. Health. 19:36–44.
  • Pal S, Chatterjee AK. (2004). Protective effect of N-acetylcysteine against arsenic-induced depletion in vivo of carbohydrate. Drug Chem. Toxicol. 27:179–189.
  • Ratnaike RN. (2003). Acute and chronic arsenic toxicity. Postgrad. Med. J. 79:391–396.
  • Repotto M. (1997). Toxilogia Fundamental. Madrid, Spain: Diaz de Santos Editions.
  • Saha KC. (1995). Chronic arsenical dermatoses from tubewell water in West Bengal during 1983–1987. Indian J. Dermatol. 40:1–12.
  • Sanz N, Diez-Fernandez C, Fernandez-Simon L, Alvarez A, Cascales M. (1995). Relationship between antioxidant systems, intracellular thiols, DNA ploidy in liver of rats during experimental cirrhogenesis. Carcinogenesis 16:1585–1593.
  • Sedlak J, Lindsay RH. (1958). Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal. Biochem. 24/25:192–205.
  • Slater TF. (1984). Free radical mechanism in tissue injury. Biochem. J. 222:1–15.
  • Smith AH, Goycolea M, Haque R, Biggs ML. (1998). Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 147:660–669.
  • Smith IK, Vierheller TL, Thorne CA. (1988). Assay of glutathione reductase in crude tissue homogenates using 5,5’-dithiobis (2-nitrobenzoic acid). Anal. Biochem. 175:408–413.
  • Sunai H, Rubin H. (1982). The role of magnesium in cell proliferation and transformation. In: Boynton, A. L., McKochan,W. L., Whitfield, J. P. (Eds.),Ions, Cell Proliferation and Cancer (pp 517–537). New York: Academic Press.
  • Tsakiris S, Angelogianni P, Schulpis KH, Stavridis JC. (2000). Protective effect of L-phenyl alanine on rat brain acetylcholinesterase inhibition induced by radicals. Clin. Biochem. 33:103–106.
  • Uchida K, Stadtman ER. (1993). Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 268:6388–6393.
  • Vahter M. (2002). Mechanism of arsenic biotransformation. Toxicology 181–182:211–217.
  • Yamauchi H, Aminaka Y, Yoshida K, Sun G, Pi J, Waalkes MP. (2004). Evaluation of DNA damage in patients with arsenic poisoning: urinary 8-hydroxydeoxyguanine. Toxicol. Appl. Pharmacol. 198:291–296.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.